‘The hinge moment’: Envisioning transformation with Amgen’s Alex Koehler

How should pharma companies respond to the current “hinge moment” where new technologies are enabling breakthroughs in drug discovery, manufacturing and customer engagement? Maria Whitman’s guest Alex Koehler, vice president and head of digital technology and innovation at Amgen, believes it’s time to be bold and move fast to capitalize on this opportunity. In this episode they discuss:

Add insights to your inbox

We’ll send you content you’ll want to read – and put to use.
Sign me up
/content/zs/en/forms/subscription-preferences
default

Meet our experts

left
white
Eyebrow Text
Button CTA Text
#
primary
default
default
tagList
/content/zs/en/insights

/content/zs/en/insights

zs:industry/pharmaceuticals-&-biotech,zs:,zs:topic/data-digital-and-technology